It was reported that 1 bd syringe 0.5ml 31ga 8mm hub separated from the device.The following information was provided by the initial reporter : material no: 32846,8 batch no: 0022157, the consumer reported that when the needle shield was removed the needle hub separated.Date of event: 2021-04-28, (needle hub separated on one 1 syringe), samples: yes.
|
The following fields were updated due to additional information: d10: device available for eval yes, d10: returned to manufacturer on: 2021-05-24.H6: investigation summary: customer returned (2) 0.5ml bd insulin syringes in an opened polybag from lot# 0022157.Consumer reported some of the needles are "dull", and stated there was some bruising.Both returned samples were examined, and it was observed that 1 syringe exhibited needle hub/shield assembly separation.No damage to the barrel tip was observed.The other returned syringe was tested for visual inspection of point geometry, outer diameter and lube coverage (specs: outer diameter for 31g cannula: 0.0100¿- 0.0105¿), and it was observed that the cannula exhibited good point geometry, measured within the outer diameter specification at 0.0103¿, and had sufficient lubrication.No defects were observed.A review of the device history record was completed for batch# 0022157.All inspections and challenges were performed per the applicable operations qc specifications.There were two (2) notifications noted that did not pertain to the complaint.Bd was able to duplicate or confirm the customer¿s indicated failure needle shield, needle hub separated.Capa pr1630423 has been opened to address this issue h3 other text : see h10.
|